May 06–09, 2024 | INEC Killarney Convention Centre, Killarney, KY, Ireland
Scientific Organizers:
Miriam Merad and Matthew F. Krummel

-
Scientific Organizers: Miriam Merad and Matthew F. Krummel
Miriam Merad
Matthew F. Krummel
***Meeting program subject to change.
Available Formats: = In PersonMerchandise Options
Registration Options
Booking Function
Fundraising
Monday, May 6, 2024
Tuesday, May 7, 2024
Session Chair
Session Chair
DC and Macrophage Diversity in Health and Diseases
Enhancing DC Function in the TME
Spatial Organization of Myeloid Programs in the TME
Myeloid Cellular Cross-Talks During Cancer Development
Short Talk: Short Talk: HLA Class II Mediated Immune Surveillance of Lung Cancer
Professor, Pathology
Founder, Managing Member, & Chief Scientific Officer
Group Leader
Session Chair
Session Chair
Antibody Targeting of Dendritic Cells in Cancer
Cell-Specific Cytokine Delivery
Short Talk: Short Talk: The TRPML1 Calcium Lysosomal Channel Controls Dendritic Cell Migration and Anti-tumor Immunity
Short Talk: Short Talk: Dendritic Cells Form and Maintain Tertiary Lymphoid Structures (TLSs) in Cancer Contributing to Immunotherapeutic Responses
Wednesday, May 8, 2024
FOLR2+ Macs and Antitumor Immunity
Metabolic Targeting of Tumor Macrophages
Myeloid Cell Engineering for Anti-Tumor Treatments
Mapping Macrophages Inflammatory Programs
Regulation of Monocyte-Derived Cells Differentiation in Inflamed Tissues
Short Talk: Short Talk: Investigate the Role of IRF5 in Macrophages and Myeloid Cells in Anti-Tumor Immunity
Short Talk: Short Talk: Understanding the Antitumoral Activity of CAR-Macrophages
ACT-VAX-INNATE: An Integrated Approach for Enhancing Tumor Control with Adoptive T Cell Therapy
Ligand-Independent TREM-1 Blockade in Cancer Treatment
IOMX-0675 , a LILRB1 and LILRB2 Cross-Specific Antibody, Effectively Repolarizes Immunosuppressive Myeloid Cells and Activates T Cells Leading to Potent Tumor Cell Killing
Lack of TREM2 During anti-PD1 Therapy Reprograms Intestinal Macrophages and Microbiota to Enhance Tumor Rejection
Cancer Enables Auxiliary Pathways of Granulopoiesis to Potentiate Tumorassociated Neutrophils
Intratumoral Delivery of Lipid Nanoparticle-Formulated mRNA Encoding IL-21, IL-7, and 4-1BBL Induces Anti-Tumor Immunity
Going the Distance: Uncovering a Global Myeloid Reprogramming in Human Metastatic and Adjacent Microenvironments
Timing and Location Dictate Monocyte Fate and Their Transition to Tumor-Associated Macrophages
Session Chair
Targeting Trem2 in Cancer Patients
Targeting Immunosupressive Macrophages
Short Talk: Short Talk: Mitochondrial NDUFA4 is a Functional Switch Controlling TAM Function and Tumor Immunity
Short Talk: Short Talk: IL-1β+ Macrophages Fuel Pathogenic Inflammation in Pancreatic Cancer
Short Talk: Short Talk: Aire-Expressing Tumor-Associated Macrophages Promote Cancer Immune Evasion
Short Talk: Short Talk: Epigenetic Dysregulation of Myeloid Progenitors Fuel Immunosuppressive Macrophages in Tumor Microenvironment
Thursday, May 9, 2024
Space-Time 'Movements' in Tissues
Bile Acids Module the Gut Immune Rheostat Tuning Cancer Immunosurveillance
A Break in Mitochondrial Endosymbiosis as a Basis for Inflammatory Diseases
Short Talk: Short Talk: Kupffer Cell-Derived MIF as Regulator of Liver Metastasis
Short Talk: Short Talk: Identification of a Tumor-Specific Macrophage Subset and its Functional Analysis by Labeling and Depletion Using the Novel VeDTR Mouse System
Targeting Myeloid Cells in Viral Diseases
Myeloid and Stromal Crosstalk in Non-Resolving Inflammation
Short Talk: Short Talk: Vaccinia-Induced Early Anti-Tumour Immune Responses Are Dependent on Differential Reprogramming of Myeloid Cell Populations in Highly Versus Weakly Immunogenic Murine Cancer Models
Friday, May 10, 2024
Subscribe for Updates